Tumor necrosis factor (TNF) antagonists for inflammatory bowel disease

References

Citations

1. Friedman S, Lichtenstein GR (2006). Crohn's disease. In MM Wolfe et al., eds., Therapy of Digestive Disorders, 2nd ed., pp. 785–801. Philadelphia: Saunders Elsevier.

2. Rutgeerts P, et al. (2005). Infliximab for induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine, 353(23): 2462–2476.

3. Sandborn WJ, et al. (February 13, 2007). Adalimumab for maintenance treatment of Crohn's disease: Results of the CLASSIC II trial. Online version of Gut, available at: http://gut.bmj.com/cgi/rapidpdf/gut.2006.106781v1.

4. Hanauer SB (2005). Inflammatory bowel diseases. In DC Dale, DD Federman, eds., ACP Medicine, section 4, chap. 4. New York: WebMD.

Author:	Monica Rhodes	Last Updated: October 24, 2006
Medical Review:	Kathleen Romito, MD - Family Medicine Arvydas D. Vanagunas, MD - Gastroenterology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.